Paul Johnson

Paul frequently speaks and writes about antitrust issues, having authored award-winning articles on EU, UK, and global competition law. He is also a member of the CELIS Institute.

Prior to joining Morgan Lewis, Paul was a partner based in the Brussels office of another international law firm.

• Represented a global leader in the digital product market in connection with the acquisition of an online course creation and sales platform
• Represented a medical device company on its $5.8 billion acquisition of a diagnostic testing company
• Represented a global pharmaceutical company on the antitrust aspects of a $4 billion acquisition of a biopharmaceutical company
• Represented a global pharmaceutical company on the antitrust aspects of a $1.95 billion acquisition of a biopharmaceutical company
• Represented a global pharmaceutical company on the antitrust aspects of a $400 million acquisition of a biopharmaceutical company
• Represented a global pharmaceutical company on the sale of a prescription drug indicated for the emergency treatment of epileptic children with prolonged acute convulsive seizures to a European leader in pharmaceutical products
• Represented a healthcare manufacturing company and a bioscience company on their microbiome joint venture before the European Commission
• Represented a hospitality company on global merger control filings with respect to its $2 billion acquisition of a hotel chain
• Represented a healthcare manufacturing company on its $5.5 billion acquisition of a drug capsule manufacturer before the European Commission
• Represented a global media company on the European Commission’s investigation into cross-border access to pay-TV content, and negotiated a settlement agreement with the case team
• Represented a payment scheme on a variety of regulatory issues including dealing with national banks and regulations in the payment sector including the Anti-Money Laundering Directive, Payment Services Directive II, Interchange Fee Regulation, and the European Central Bank’s proposal on cyber resilience
• Represented a major global financial institution with respect to a number of investigations concerning potentially collusive behavior
• Represented a major global insurance institution on Brexit, and developed options to ensure continued access to the EU single market
• Represented a major insurance company on the London Market dry-run that tested the resilience of the world’s preeminent insurance market to a major loss event